Jennifer Herron is the Senior Vice President & Chief Commercial Officer at ADC Therapeutics.
Jennifer Herron is Senior Vice President and Chief Commercial Officer of ADC Therapeutics, spearheading global commercialization strategy and execution. She is a seasoned biopharma leader with extensive oncology product launch experience.
Before joining ADC Therapeutics, Ms. Herron was Executive Vice President and Chief Commercial Officer at Immunogen. She previously served as President and Executive Vice President, Global Commercial, at MorphoSys US and Executive Vice President and Chief Commercial Officer at Ariad Pharmaceuticals. Earlier in her career, she held commercial leadership roles in major multinational pharmaceutical companies such as Bristol-Myers Squibb, Novartis Oncology, and SmithKline Beecham Oncology (GlaxoSmithKline).
Ms. Herron holds an MBA from Georgetown University and a BA in Biology and Economics from Lehigh University.